Interestingly, due to the positive correlation between DOCK8 expression and the level of immune cell infiltration in TME, DOCK8 could be considered a prognostic biomarker for HNSCC (Zhang et al., 2021). This evidence concerns the gene DOCK8 and head and neck squamous cell carcinoma.